These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34786862)

  • 1. 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation.
    Sharma B; Kumar S; Preeti ; Johansen MD; Kremer L; Kumar V
    Chem Biol Drug Des; 2022 Feb; 99(2):301-307. PubMed ID: 34786862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
    Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
    Ding Z; Hou P; Liu B
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
    Abdu-Allah HH; Youssif BG; Abdelrahman MH; Abdel-Hamid MK; Reshma RS; Yogeeswari P; Aboul-Fadl T; Sriram D
    Arch Pharm Res; 2017 Feb; 40(2):168-179. PubMed ID: 28028696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
    Yan X; Lv Z; Wen J; Zhao S; Xu Z
    Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
    Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
    Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
    Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
    Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities.
    Gao F; Chen Z; Ma L; Qiu L; Lin J; Lu G
    Bioorg Med Chem; 2019 Jun; 27(12):2652-2656. PubMed ID: 30992202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
    Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
    Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
    Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivatives.
    Trotsko N; Golus J; Kazimierczak P; Paneth A; Przekora A; Ginalska G; Wujec M
    Bioorg Chem; 2020 Apr; 97():103676. PubMed ID: 32097795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives.
    Xu Y; Guan J; Xu Z; Zhao S
    Fitoterapia; 2018 Jun; 127():383-386. PubMed ID: 29631015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
    Kim S; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.